Gibson, Dunn & Crutcher LLP advised Merck on its acquisition of Caraway Therapeutics, Inc. Merck (NYSE: MRK), known as MSD outside of the United States and...
Merck’s Acquisition of Caraway Therapeutics, Inc.
Daiichi Sankyo and Merck’s Global Development and Commercialization Collaboration for Three Daiichi Sankyo DXd ADCs
Gibson, Dunn & Crutcher LLP is advising Merck on the agreement. Daiichi Sankyo (TSE: 4568) and Merck (known as MSD outside of the United States and...
ExxonMobil’s $64.5 Billion Acquisition of Pioneer Natural Resources
Citi acted as lead financial advisor, Centerview Partners as financial advisor, and Davis Polk & Wardwell as legal advisor to ExxonMobil. Goldman Sachs, Morgan Stanley, Petrie...
Patterson-UTI’s $370 Million Acquisition of Ulterra
Gibson, Dunn & Crutcher LLP is advising Patterson-UTI Energy, Inc., while Kirkland & Ellis is advising Blackstone Energy Partners in the transaction. Patterson-UTI Energy, Inc. (NASDAQ:PTEN)...
NexTier’s $5.4 Billion Merger of Equals With Patterson-UTI
Kirkland & Ellis LLP is serving as legal advisor to NexTier, while Gibson, Dunn & Crutcher LLP is serving as legal advisor to Patterson-UTI. Patterson-UTI Energy,...